Orion Pharma Ltd. Corporate Structure and Shareholder Information

Orion Pharma Ltd. is a company with a well-defined corporate structure. The company is headquartered in Espoo, Finland.

Orion Pharma Ltd. has a clear ownership structure, with the majority of shares held by the public. The company's shares are listed on the NASDAQ OMX Helsinki stock exchange.

Orion Pharma Ltd. has a strong foundation, with a history dating back to 1917.

Worth a look: Abbvie Company Profile

Orion Pharma Ltd. has seen significant fluctuations in its sales over the years, with a notable increase in power sales from 5.35B in 2020 to 10.87B in 2023.

The company's power sales have been steadily increasing, with a peak in 2023. In contrast, its pharmaceutical sales have been relatively stable, ranging from 2.3B to 3.67B between 2020 and 2024.

Here's a breakdown of Orion Pharma Ltd.'s sales by activity:

Sales by Activity is a key metric for any business, and Orion Pharma Limited is no exception. According to the data, the company's sales have fluctuated over the past few years.

In 2020, Orion Pharma Limited's sales from Power reached a staggering $5.35 billion. This figure more than doubled in 2021, reaching $8.22 billion.

The company's sales from Pharmaceuticals have also seen growth, increasing from $2.3 billion in 2020 to $2.61 billion in 2021.

Here's a breakdown of the company's sales by activity over the past few years:

As you can see, the company's sales from Power have experienced a significant dip in 2022 and 2024, while sales from Pharmaceuticals have continued to grow.

Orion Pharma Limited's sales performance varies significantly across different regions. The company has a substantial presence in Bangladesh, with sales increasing from 2.14 billion in 2020 to 3.52 billion in 2024.

In contrast, the company's sales in Unallocated and Export categories have seen fluctuations over the years. The Unallocated category has seen the highest sales, reaching 10.87 billion in 2023.

Here's a breakdown of the company's sales by region:

The Export category has seen a slight increase in sales over the years, with the highest sales of 200 million in 2023.

Orion Pharma Ltd. is dedicated to serving its valued customers with products of excellent quality through continuous improvement in technology, process, and human resources complying with the guidelines of Good Manufacturing Practice (GMP) and the requirements of ISO-9001: 2008 Quality Management System (QMS).

The company has a strong commitment to quality and adheres to international standards. Orion Pharma Ltd. is going to build one of the finest facilities for pharmaceutical finished products in south-east Asia, created in accordance with the Current Good Manufacturing Practices (cGMP) standards of international regulatory authorities like USFDA, UK MHRA, Health Canada, Australian TGA, etc.

Orion Pharma Ltd. is headquartered at Orion House, 153-154 Tejgaon Industrial Area, Dhaka-1208, Bangladesh, with contact details including phone numbers and email address.

Intriguing read: Cukurova Finance International Ltd V Alfa Telecom Turkey Ltd

Orion Pharma Limited Bangladesh is a top-tier pharmaceutical company dedicated to improving human healthcare in the country.

They provide a range of pharmaceutical products of excellent quality, complying with Good Manufacturing Practice (GMP) and ISO-9001: 2008 Quality Management System (QMS) guidelines.

See what others are reading: Quality Chemicals Limited

Their facilities will be built in accordance with Current Good Manufacturing Practices (cGMP) standards of international regulatory authorities like USFDA, UK MHRA, Health Canada, and Australian TGA.

Orion Pharma Limited Bangladesh has a product list available online, which can be browsed from their website.

Their corporate office is located at Orion House, 153-154 Tejgaon Industrial Area, Dhaka-1208, Bangladesh.

You can contact them via phone at + 88 02 8870130, 8870133, 8870134 or via email at [email protected].

Their website is www.orionpharmabd.com.

Consider reading: MJL Bangladesh Limited

Corporate actions are an essential part of a company's corporate structure, and they can have a significant impact on shareholders.

A corporate action is a decision made by a company's board of directors that affects the company's capital structure or the rights of its shareholders. This can include dividend payouts, stock splits, and rights issues.

Let's take a look at some examples of corporate actions. In the case of the company we're examining, there were several notable corporate actions between 2015 and 2018.

Here are some examples of corporate actions for this company:

These corporate actions demonstrate the importance of staying up-to-date on a company's activities and decisions.

The Board of Directors is a crucial part of any company's corporate structure, and Orion Pharma Limited is no exception.

Mohammad Obaidul Karim serves as the Chairman of the Board, a position he has held since 2014.

The Board consists of six members, with Arzuda Karim, Salman Obaidul Karim, Zareen Karim, and Hasina Begum serving as Directors/Board Members.

A. N. M. Abul Kashem is also a Director/Board Member, having joined the Board in 2019.

Here's a breakdown of the Board's composition:

Orion Pharma Ltd. has a diverse group of shareholders.

Mohammad Obaidul Karim holds the largest share of 15.18% with a valuation of 11 million BDT.

Panbo Bangla Mushroom Ltd. is another significant shareholder with a 6.154% stake valued at 4 million BDT.

Salman Obaidul Karim also has a notable share of 4.149% worth 3 million BDT.

Arzuda Karim and Zareen Karim are also part of the company's ownership structure, holding 3.763% and 2.741% stakes respectively.

Here is a breakdown of the top shareholders: